Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRV734 for Opioid Withdrawal in OUD
NCT04316559Phase 2Terminated
- Sponsor
- National Institute on Drug Abuse
- Start
- Dec 2021
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TRV734 in opioid withdrawal (2 arms), sponsored by National Institute on Drug Abuse. Primary endpoint: Subjective Opioid Withdrawal Scale. Started Dec 2021; status: terminated.
02
Drugs
TRV734
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on NCT04316559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04316559.